Cavaletti, G.; Pizzamiglio, C.; Man, A.; Engber, T.M.; Comi, C.; Wilbraham, D.
Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy. Cancers 2023, 15, 4216.
https://doi.org/10.3390/cancers15174216
AMA Style
Cavaletti G, Pizzamiglio C, Man A, Engber TM, Comi C, Wilbraham D.
Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy. Cancers. 2023; 15(17):4216.
https://doi.org/10.3390/cancers15174216
Chicago/Turabian Style
Cavaletti, Guido, Chiara Pizzamiglio, Albert Man, Thomas M. Engber, Cristoforo Comi, and Darren Wilbraham.
2023. "Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy" Cancers 15, no. 17: 4216.
https://doi.org/10.3390/cancers15174216
APA Style
Cavaletti, G., Pizzamiglio, C., Man, A., Engber, T. M., Comi, C., & Wilbraham, D.
(2023). Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy. Cancers, 15(17), 4216.
https://doi.org/10.3390/cancers15174216
